<DOC>
	<DOC>NCT02160574</DOC>
	<brief_summary>This is a safety study to determine the cumulative skin irritation potential of ZuraPrep™ and ZuraPrep™ without Isopropyl Alcohol after repetitive patch applications to skin of human subjects.</brief_summary>
	<brief_title>Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA</brief_title>
	<detailed_description>This cumulative irritation evaluation is designed to determine the skin irritation potential of ZuraPrep™ and ZuraPrep™ without Isopropyl Alcohol (IPA) after repetitive patch application to skin of healthy human subjects.</detailed_description>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>Subjects may be of either sex, at least 18 years of age and of any race Subjects must be free of tattoos, sunburn, dermatoses, cuts, lesions or other disorders of the skin of the back. Subjects must be in good general health Known allergies to latex, metals, tape and/or adhesives, soap, citric acid, methylene blue, methylparaben, propylparaben, chlorhexidine gluconate, isopropyl alcohol, and sodium lauryl sulfate. Exposure of the back region to antimicrobial agents, medicated soaps, medicated shampoos, medicated lotions, strong detergents, suntanning, use of tanning beds, or swimming or soaking in pools or hot tubs, in the 7 days prior to, or during the 3week test period. Use of topical or systemic corticosteroid, antihistamine, or antiinflammatory medications in the 7 days prior to, or during the 3week test period. Current or recent severe illness such as asthma, diabetes, hepatitis, organ transplant, mitral valve prolapse, congenital heart disease, internal prostheses, or any immunocompromised condition such as AIDS or HIV positive. Pregnancy, plans to become pregnant, breastfeeding Any active skin rash or breaks in the skin of the back Any sunburn or tattoos on the skin of the back Current active skin disease or inflammatory skin condition including contact dermatitis Participation in a clinical study in the past 7 days or current participation in another clinical study Any medical condition or use of any medications that, in the opinion of the Principal Investigator, would preclude participation Unwillingness to fulfill the performance requirements of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>